%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Cécile Jovelet, Jordan Madic, Jordi Remon, Aurélie Honoré, Romain Girard, Etienne Rouleau, Barbara André, Benjamin Besse, Magali Droniou, Ludovic Lacroix
Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 12 0 R/Contents 13 0 R/TrimBox[0 0 612 792]>>
endobj
12 0 obj
[14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R]
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref001)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref002)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref003)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref004)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref005)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref006)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref007)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref007)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref009)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref010)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref010)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref011)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref010)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref012)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref013)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref014)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref015)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref013)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref016)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref018)>>
endobj
34 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183319.ref019)>>
endobj
35 0 obj
<>/Border[0 0 0]/A 36 0 R>>
endobj
36 0 obj
<>
endobj
13 0 obj
[37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R]
endobj
37 0 obj
<>stream
q
0.83 0.64 0.02 0 k
251.9433 706.337 m
256.7055 706.337 l
h
f*
395.7165 680.315 m
400.4787 680.315 l
h
f*
491.9244 615.3449 m
496.6866 615.3449 l
h
f*
203.4142 550.3181 m
208.1764 550.3181 l
h
f*
210.3874 550.3181 m
215.1496 550.3181 l
h
f*
387.1559 537.3354 m
391.8614 537.3354 l
h
f*
426.3307 485.348 m
431.0929 485.348 l
h
f*
507.4016 459.326 m
512.1638 459.326 l
h
f*
517.3795 459.326 m
522.085 459.326 l
h
f*
315.2693 420.3213 m
324.7937 420.3213 l
h
f*
233.2913 407.3386 m
242.7591 407.3386 l
h
f*
245.0268 407.3386 m
254.5512 407.3386 l
h
f*
462.7843 381.3165 m
472.3087 381.3165 l
h
f*
477.4677 381.3165 m
486.9921 381.3165 l
h
f*
440.7874 355.3512 m
450.3118 355.3512 l
h
f*
455.4709 355.3512 m
464.9953 355.3512 l
h
f*
432.6803 303.3071 m
442.2047 303.3071 l
h
f*
241.0583 264.3024 m
250.5827 264.3024 l
h
f*
514.7717 186.3496 m
524.2394 186.3496 l
h
f*
529.4551 186.3496 m
538.9795 186.3496 l
h
f*
548.9575 147.3449 m
558.4819 147.3449 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(lung)Tj
2.0069 0 Td
(cancer)Tj
2.8459 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.5988 0 Td
(About)Tj
2.7439 0 Td
(16%)Tj
1.9275 0 Td
(of)Tj
1.0148 0 Td
(non-small-cell)Tj
5.9754 0 Td
(lung)Tj
2.0069 0 Td
(cancers)Tj
3.2032 0 Td
(\(NSCLC\))Tj
3.9798 0 Td
(are)Tj
1.4456 0 Td
(diagnosed)Tj
4.2803 0 Td
(at)Tj
0.9525 0 Td
(localized)Tj
-33.9815 -1.3039 Td
(stage,)Tj
2.4264 0 Td
(where)Tj
2.6475 0 Td
(surgery)Tj
3.1975 0 Td
(remains)Tj
3.4469 0 Td
(the)Tj
1.4683 0 Td
(standard)Tj
3.7191 0 Td
(treatment,)Tj
4.3653 0 Td
(while)Tj
2.3697 0 Td
(22%)Tj
1.9276 0 Td
(are)Tj
1.4457 0 Td
(diagnosed)Tj
4.2802 0 Td
(at)Tj
0.9525 0 Td
(locally)Tj
2.7779 0 Td
(ad-)Tj
-35.0246 -1.2982 Td
(vanced)Tj
3.033 0 Td
(disease)Tj
3.016 0 Td
(and)Tj
1.7292 0 Td
(up)Tj
1.2642 0 Td
(to)Tj
1.0261 0 Td
(60%)Tj
1.9276 0 Td
(in)Tj
1.0375 0 Td
(advanced)Tj
3.9911 0 Td
(stage)Tj
2.2054 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(].)Tj
1.5987 0 Td
(Conventional)Tj
5.6693 0 Td
(chemotherapy)Tj
5.947 0 Td
(is)Tj
0.8504 0 Td
(frequently)Tj
-33.2955 -1.2983 Td
(confronted)Tj
4.6601 0 Td
(to)Tj
1.0261 0 Td
(resistance)Tj
4.1329 0 Td
(mechanisms)Tj
5.2044 0 Td
(in)Tj
1.0375 0 Td
(advanced)Tj
3.9911 0 Td
(NSCLC)Tj
3.2995 0 Td
(due)Tj
1.7008 0 Td
(to)Tj
1.0205 0 Td
(the)Tj
1.474 0 Td
(selection)Tj
3.719 0 Td
(of)Tj
1.0148 0 Td
(molecular)Tj
-32.2807 -1.2983 Td
(alterations)Tj
4.4106 0 Td
(in)Tj
1.0318 0 Td
(tumor)Tj
2.744 0 Td
(cells.)Tj
2.1486 0 Td
(The)Tj
1.7801 0 Td
(introduction)Tj
5.3121 0 Td
(of)Tj
1.0148 0 Td
(targeted)Tj
3.464 0 Td
(therapies)Tj
3.8437 0 Td
(has)Tj
1.542 0 Td
(changed)Tj
3.5717 0 Td
(the)Tj
1.4683 0 Td
(treatment)Tj
-32.3317 -1.3039 Td
(paradigm)Tj
4.0535 0 Td
(and)Tj
1.7291 0 Td
(has)Tj
1.5477 0 Td
(established)Tj
4.5921 0 Td
(tumor)Tj
2.7439 0 Td
(genotyping)Tj
4.7168 0 Td
(as)Tj
1.0148 0 Td
(an)Tj
1.2019 0 Td
(essential)Tj
3.583 0 Td
(routine)Tj
3.1634 0 Td
(diagnostic)Tj
4.32 0 Td
(tool)Tj
1.7801 0 Td
(in)Tj
1.0375 0 Td
(clini-)Tj
-35.4838 -1.2982 Td
(cal)Tj
1.3209 0 Td
(practice.)Tj
3.6056 0 Td
(In)Tj
1.1112 0 Td
(Caucasian)Tj
4.3086 0 Td
(population,)Tj
/F13 1 Tf
4.8189 0 Td
[()]TJ
/F8 1 Tf
2.5512 0 Td
(activating)Tj
4.1102 0 Td
(mutations)Tj
4.2803 0 Td
(account)Tj
3.3788 0 Td
(for)Tj
1.389 0 Td
(approximately)Tj
-30.8747 -1.2983 Td
(11%)Tj
1.9275 0 Td
(of)Tj
1.0148 0 Td
(genetic)Tj
3.0671 0 Td
(alterations)Tj
4.4106 0 Td
(in)Tj
1.0375 0 Td
(advanced)Tj
3.9912 0 Td
(NSCLC,)Tj
3.5262 0 Td
(mainly)Tj
2.9877 0 Td
(adenocarcinoma)Tj
6.8882 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
1.6044 0 Td
(In)Tj
1.1055 0 Td
(patients)Tj
3.3675 0 Td
(har-)Tj
-34.9282 -1.3039 Td
(bouring)Tj
3.4128 0 Td
(sensitizing)Tj
/F13 1 Tf
4.4391 0 Td
[()]TJ
/F8 1 Tf
2.5511 0 Td
(mutations,)Tj
4.5071 0 Td
(especially)Tj
4.0195 0 Td
(small)Tj
2.3244 0 Td
(in-frame)Tj
3.7247 0 Td
(deletion/insertions)Tj
7.7442 0 Td
(in)Tj
1.0318 0 Td
(exon)Tj
2.1657 0 Td
(19)Tj
-35.9204 -1.2983 Td
(\()Tj
/F13 1 Tf
[()]TJ
/F8 1 Tf
2.8856 0 Td
(Del19\))Tj
2.9083 0 Td
(and)Tj
1.7235 0 Td
(p.L858R)Tj
3.5433 0 Td
(mutation)Tj
3.9174 0 Td
(in)Tj
1.0318 0 Td
(exon)Tj
2.1543 0 Td
(21,)Tj
1.3947 0 Td
(inhibition)Tj
4.2179 0 Td
(of)Tj
/F13 1 Tf
1.0091 0 Td
[()]TJ
/F8 1 Tf
2.5455 0 Td
(kinase)Tj
2.744 0 Td
(activity)Tj
3.1124 0 Td
(by)Tj
1.1735 0 Td
(tyrosine)Tj
-34.3613 -1.2983 Td
(kinase)Tj
2.7495 0 Td
(inhibitors)Tj
4.1443 0 Td
(\(EGFR-TKIs\))Tj
5.6692 0 Td
(improves)Tj
3.9402 0 Td
(response)Tj
3.736 0 Td
(rate)Tj
1.7461 0 Td
(and)Tj
1.7291 0 Td
(progression-free)Tj
6.7748 0 Td
(survival)Tj
3.3392 0 Td
(com-)Tj
-33.8284 -1.3039 Td
(pared)Tj
2.4944 0 Td
(to)Tj
1.0262 0 Td
(standard)Tj
3.719 0 Td
(first-line)Tj
3.6397 0 Td
(platinum)Tj
3.8834 0 Td
(doublet)Tj
3.2541 0 Td
(chemotherapy,)Tj
6.1739 0 Td
(making)Tj
3.2541 0 Td
(them)Tj
2.2904 0 Td
(the)Tj
1.4683 0 Td
(standard)Tj
3.7191 0 Td
(of)Tj
1.0148 0 Td
(care)Tj
-35.9374 -1.2982 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
/F13 1 Tf
2.3017 0 Td
[()]TJ
/F8 1 Tf
2.5511 0 Td
(mutations)Tj
4.2803 0 Td
(profiling)Tj
3.6964 0 Td
(is)Tj
0.8504 0 Td
(therefore)Tj
3.8551 0 Td
(a)Tj
0.6519 0 Td
(critical)Tj
2.948 0 Td
(step)Tj
1.8199 0 Td
(in)Tj
1.0374 0 Td
(identifying)Tj
4.5751 0 Td
(the)Tj
1.474 0 Td
(patients)Tj
3.3676 0 Td
(with)Tj
-33.4089 -1.2983 Td
(increased)Tj
3.9968 0 Td
(sensitivity)Tj
4.2236 0 Td
(to)Tj
1.0261 0 Td
(EGFR-TKIs)Tj
4.989 0 Td
(treatment)Tj
4.1385 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(].)Tj
1.5987 0 Td
(Unfortunately,)Tj
6.1285 0 Td
(almost)Tj
2.8857 0 Td
(all)Tj
1.1451 0 Td
(patients)Tj
3.3676 0 Td
(will)Tj
-33.4996 -1.3039 Td
(develop)Tj
3.3165 0 Td
(acquired)Tj
3.702 0 Td
(resistance)Tj
4.1329 0 Td
(to)Tj
1.0261 0 Td
(EGFR-TKIs.)Tj
5.2157 0 Td
(Mechanisms)Tj
5.2781 0 Td
(of)Tj
1.0148 0 Td
(acquired)Tj
3.702 0 Td
(resistance)Tj
4.1329 0 Td
(may)Tj
1.9276 0 Td
(be)Tj
1.1508 0 Td
(catego-)Tj
-34.5994 -1.2983 Td
(rized)Tj
2.2223 0 Td
(as:)Tj
1.2416 0 Td
(\(1\))Tj
1.3719 0 Td
(secondary)Tj
/F13 1 Tf
4.2746 0 Td
[()]TJ
/F8 1 Tf
2.5455 0 Td
(mutations,)Tj
4.5071 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(mutations)Tj
4.2803 0 Td
(in)Tj
1.0375 0 Td
(exon)Tj
2.16 0 Td
(20)Tj
1.1735 0 Td
(\(2\))Tj
1.3776 0 Td
(bypass)Tj
2.8517 0 Td
(track)Tj
2.245 0 Td
(signal-)Tj
-34.367 -1.2982 Td
(ling)Tj
1.7461 0 Td
(pathways)Tj
3.9288 0 Td
(like)Tj
/F13 1 Tf
1.6554 0 Td
[()14()]TJ
/F8 1 Tf
2.228 0 Td
(or)Tj
/F13 1 Tf
1.0999 0 Td
[()]TJ
/F8 1 Tf
2.5625 0 Td
(amplification,)Tj
5.7599 0 Td
(or)Tj
1.0999 0 Td
(\(3\))Tj
1.3776 0 Td
(histologic)Tj
4.0875 0 Td
(transformation)Tj
6.2759 0 Td
(mainly)Tj
2.9877 0 Td
(to)Tj
-34.8092 -1.2983 Td
(small-cell)Tj
4.0138 0 Td
(carcinoma)Tj
4.4503 0 Td
(with)Tj
1.9956 0 Td
(or)Tj
1.0999 0 Td
(without)Tj
/F13 1 Tf
3.3278 0 Td
[( )14(\n)36(\r)]TJ
/F8 1 Tf
3.4809 0 Td
(mutation)Tj
3.9232 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
1.5987 0 Td
(The)Tj
1.7858 0 Td
(substitution)Tj
4.989 0 Td
(of)Tj
1.0148 0 Td
(threonine)Tj
4.1328 0 Td
(to)Tj
-35.8126 -1.3039 Td
(methionine)Tj
4.8472 0 Td
(at)Tj
0.9524 0 Td
(codon)Tj
2.7382 0 Td
(790)Tj
1.6441 0 Td
(\(p.T790M\))Tj
4.5751 0 Td
(in)Tj
1.0375 0 Td
(exon)Tj
2.16 0 Td
(20)Tj
1.1735 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
/F13 1 Tf
1.4684 0 Td
[()]TJ
/F8 1 Tf
2.5511 0 Td
(gene)Tj
2.0806 0 Td
(decreases)Tj
3.9685 0 Td
(sensitivity)Tj
4.2236 0 Td
(to)Tj
1.0205 0 Td
(first-)Tj
-35.4555 -1.2983 Td
(generation)Tj
4.507 0 Td
(EGFR-TKIs)Tj
4.989 0 Td
(and)Tj
1.7291 0 Td
(accounts)Tj
3.7474 0 Td
(for)Tj
1.3833 0 Td
(over)Tj
1.9785 0 Td
(half)Tj
1.7121 0 Td
(of)Tj
1.0148 0 Td
(resistance)Tj
4.1329 0 Td
(mechanisms)Tj
5.2044 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(].)Tj
2.5965 0 Td
(Osimerti-)Tj
-32.995 -1.2983 Td
(nib)Tj
1.542 0 Td
(\(AZD9291\),)Tj
5.0456 0 Td
(a)Tj
0.6577 0 Td
(third-generation)Tj
6.8484 0 Td
(EGFR-TKI)Tj
4.6318 0 Td
(with)Tj
1.9956 0 Td
(activity)Tj
3.1181 0 Td
(against)Tj
3.0274 0 Td
(sensitive)Tj
3.6226 0 Td
(and)Tj
1.7348 0 Td
(resistant)Tj
/F13 1 Tf
-32.224 -1.3039 Td
[()]TJ
/F8 1 Tf
2.5511 0 Td
(mutations,)Tj
4.5071 0 Td
(is)Tj
0.8447 0 Td
(the)Tj
1.4683 0 Td
(standard)Tj
3.7247 0 Td
(treatment)Tj
4.1329 0 Td
(in)Tj
/F13 1 Tf
1.0375 0 Td
[()]TJ
/F8 1 Tf
(-positive)Tj
6.5253 0 Td
(NSCLC)Tj
3.2938 0 Td
(patients)Tj
3.3732 0 Td
(after)Tj
2.0353 0 Td
(disease-)Tj
-33.4939 -1.2982 Td
(progression)Tj
4.9209 0 Td
(on)Tj
1.2755 0 Td
(EGFR-TKIs)Tj
4.989 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(],)Tj
2.0749 0 Td
(and)Tj
1.7292 0 Td
(it)Tj
0.788 0 Td
(has)Tj
1.542 0 Td
(received)Tj
3.5376 0 Td
(the)Tj
1.4684 0 Td
(approval)Tj
3.702 0 Td
(by)Tj
1.1792 0 Td
(FDA)Tj
2.1713 0 Td
(and)Tj
1.7292 0 Td
(EMA.)Tj
2.5908 0 Td
(Recent)Tj
-33.698 -1.2983 Td
(studies)Tj
2.9876 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(],)Tj
3.2485 0 Td
(have)Tj
2.0636 0 Td
(reported)Tj
3.6567 0 Td
(the)Tj
1.474 0 Td
(feasibility)Tj
4.0309 0 Td
(of)Tj
1.0148 0 Td
(liquid)Tj
2.5625 0 Td
(biopsies)Tj
3.4299 0 Td
(for)Tj
1.3889 0 Td
(testing)Tj
2.88 0 Td
(T790M)Tj
3.1521 0 Td
(and)Tj
1.7291 0 Td
(personal-)Tj
-33.6186 -1.3039 Td
(ising)Tj
2.1259 0 Td
(treatment)Tj
4.1386 0 Td
(among)Tj
2.9933 0 Td
(lung)Tj
2.007 0 Td
(cancer)Tj
2.8459 0 Td
(patients;)Tj
3.5943 0 Td
(and)Tj
1.7292 0 Td
(efficacy)Tj
3.2201 0 Td
(of)Tj
1.0148 0 Td
(osimertinib)Tj
4.8585 0 Td
(is)Tj
0.8504 0 Td
(equivalent)Tj
4.3484 0 Td
(irrespec-)Tj
-33.7264 -1.2983 Td
(tive)Tj
1.661 0 Td
(if)Tj
0.7767 0 Td
(T790M-positive)Tj
6.599 0 Td
(status)Tj
2.5002 0 Td
(is)Tj
0.8447 0 Td
(detected)Tj
3.566 0 Td
(in)Tj
1.0374 0 Td
(tissue)Tj
2.4605 0 Td
(or)Tj
1.0942 0 Td
(liquid)Tj
2.5625 0 Td
(biopsy)Tj
2.8346 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
-24.7406 -1.2983 Td
(Development)Tj
5.6239 0 Td
(of)Tj
1.0148 0 Td
(analysis)Tj
3.3221 0 Td
(performed)Tj
4.4731 0 Td
(on)Tj
1.2756 0 Td
(plasma)Tj
3.0274 0 Td
(circulating)Tj
4.4957 0 Td
(cell)Tj
1.559 0 Td
(free)Tj
1.7235 0 Td
(DNA)Tj
2.3811 0 Td
(\(cfDNA\))Tj
3.7643 0 Td
(offers)Tj
2.4605 0 Td
(a)Tj
-36.3172 -1.2982 Td
(blood-based)Tj
5.1193 0 Td
(minimally-invasive)Tj
7.8803 0 Td
(alternative)Tj
4.422 0 Td
(to)Tj
1.0261 0 Td
(tissue)Tj
2.4548 0 Td
(biopsy)Tj
2.8346 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
3.549 0 Td
(Indeed,)Tj
3.2371 0 Td
(potential)Tj
3.7587 0 Td
(applica-)Tj
-34.2819 -1.3039 Td
(tions)Tj
2.1996 0 Td
(of)Tj
1.0148 0 Td
(cfDNA)Tj
3.0898 0 Td
(based)Tj
2.4718 0 Td
(analysis,)Tj
3.5546 0 Td
(even)Tj
2.0693 0 Td
(when)Tj
2.4037 0 Td
(tissue)Tj
2.4548 0 Td
(sample)Tj
3.0217 0 Td
(is)Tj
0.8504 0 Td
(not)Tj
1.5761 0 Td
(available,)Tj
3.8891 0 Td
(include)Tj
3.1861 0 Td
(molecular)Tj
-31.7818 -1.2983 Td
(abnormalities)Tj
5.7032 0 Td
(characterization)Tj
6.6614 0 Td
(opportunity)Tj
5.0343 0 Td
(at)Tj
0.9524 0 Td
(diagnosis,)Tj
4.1839 0 Td
(patient)Tj
3.0104 0 Td
(selection)Tj
3.719 0 Td
(for)Tj
1.3833 0 Td
(targeted)Tj
3.464 0 Td
(thera-)Tj
-34.1119 -1.2983 Td
(pies,)Tj
2.0125 0 Td
(prognostic)Tj
4.4844 0 Td
(assessment,)Tj
4.8416 0 Td
(monitoring)Tj
4.8188 0 Td
(of)Tj
1.0148 0 Td
(treatment)Tj
4.1329 0 Td
(response)Tj
3.7361 0 Td
(and)Tj
1.7291 0 Td
(resistance,)Tj
4.354 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8198 0 Td
(as)Tj
-33.9588 -1.3039 Td
(screening)Tj
4.0421 0 Td
(for)Tj
1.372 0 Td
(acquired)Tj
3.6963 0 Td
(mutations)Tj
4.269 0 Td
(at)Tj
0.9411 0 Td
(the)Tj
1.4627 0 Td
(time)Tj
2.0182 0 Td
(of)Tj
1.0035 0 Td
(resistance)Tj
4.1215 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(].)Tj
2.0636 0 Td
(Currently,)Tj
4.3427 0 Td
(detection)Tj
3.9288 0 Td
(of)Tj
1.0034 0 Td
(mutated)Tj
-34.2649 -1.2982 Td
(circulating)Tj
4.49 0 Td
(DNA)Tj
2.3754 0 Td
(remains)Tj
3.4469 0 Td
(a)Tj
0.652 0 Td
(challenging)Tj
4.8189 0 Td
(analytic)Tj
3.3278 0 Td
(owing)Tj
2.6929 0 Td
(to)Tj
1.0205 0 Td
(its)Tj
1.1508 0 Td
(occurrence)Tj
4.6602 0 Td
(in)Tj
1.0374 0 Td
(small)Tj
2.3244 0 Td
(fragments)Tj
-31.9972 -1.2983 Td
(and)Tj
1.7291 0 Td
(its)Tj
1.1452 0 Td
(low)Tj
1.6611 0 Td
(proportion)Tj
4.6317 0 Td
(of)Tj
1.0148 0 Td
(tumor)Tj
2.744 0 Td
(mutated)Tj
3.5489 0 Td
(cfDNA)Tj
3.0841 0 Td
(\(ctDNA\))Tj
3.7814 0 Td
(in)Tj
1.0374 0 Td
(total)Tj
2.0013 0 Td
(circulating)Tj
4.49 0 Td
(cell-free)Tj
3.4186 0 Td
(DNA)Tj
-34.2876 -1.3039 Td
(\(cfDNA\))Tj
3.7643 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
2.0807 0 Td
(However,)Tj
4.0761 0 Td
(it)Tj
0.7824 0 Td
(is)Tj
0.8504 0 Td
(not)Tj
1.576 0 Td
(well)Tj
1.8199 0 Td
(established)Tj
4.5977 0 Td
(what)Tj
2.16 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4684 0 Td
(best)Tj
1.8084 0 Td
(technique)Tj
4.167 0 Td
(for)Tj
1.3889 0 Td
(molecular)Tj
-31.3906 -1.2983 Td
(profiling)Tj
3.6963 0 Td
(in)Tj
1.0375 0 Td
(liquid)Tj
2.5625 0 Td
(biopsies.)Tj
3.6567 0 Td
(Recent)Tj
2.9593 0 Td
(improvement)Tj
5.6693 0 Td
(of)Tj
1.0148 0 Td
(PCR-based)Tj
4.6658 0 Td
(methods,)Tj
3.9117 0 Td
(massive)Tj
3.3392 0 Td
(parallel)Tj
-32.5131 -1.2983 Td
(sequencing)Tj
4.7168 0 Td
(\(MPS\))Tj
2.8233 0 Td
(and)Tj
1.7291 0 Td
(digital)Tj
2.7269 0 Td
(PCR)Tj
2.0636 0 Td
(now)Tj
1.9616 0 Td
(enable)Tj
2.8006 0 Td
(reliable)Tj
3.1407 0 Td
(detection)Tj
3.9402 0 Td
(and)Tj
1.7291 0 Td
(quantification)Tj
5.8337 0 Td
(of)Tj
1.0148 0 Td
(muta-)Tj
-34.4804 -1.3039 Td
(tion)Tj
1.8425 0 Td
(in)Tj
1.0318 0 Td
(cfDNA,)Tj
3.3165 0 Td
(thereby)Tj
3.2258 0 Td
(opening)Tj
3.4979 0 Td
(up)Tj
1.2643 0 Td
(possibilities)Tj
4.8698 0 Td
(for)Tj
1.3833 0 Td
(clinical)Tj
3.0785 0 Td
(use.)Tj
1.7574 0 Td
(Digital)Tj
2.931 0 Td
(droplet)Tj
3.1124 0 Td
(PCR)Tj
2.0637 0 Td
(\(dPCR\))Tj
-33.3749 -1.2982 Td
(involve)Tj
3.118 0 Td
(partition)Tj
3.7304 0 Td
(of)Tj
1.0148 0 Td
(target)Tj
2.5115 0 Td
(DNA)Tj
2.3754 0 Td
(templates)Tj
4.0422 0 Td
(into)Tj
1.8425 0 Td
(water)Tj
2.4321 0 Td
(in)Tj
1.0318 0 Td
(oil)Tj
1.2416 0 Td
(emulsion)Tj
3.9231 0 Td
(followed)Tj
3.651 0 Td
(by)Tj
1.1792 0 Td
(PCR)Tj
2.0636 0 Td
(amplifi-)Tj
-34.1572 -1.2983 Td
(cation)Tj
2.6985 0 Td
(and)Tj
1.7291 0 Td
(end-point)Tj
4.2066 0 Td
(quantification)Tj
5.8394 0 Td
(of)Tj
1.0148 0 Td
(amplified)Tj
4.0081 0 Td
(partitions)Tj
4.0932 0 Td
(using)Tj
2.3868 0 Td
(fluorescent)Tj
4.6374 0 Td
(signal,)Tj
2.7666 0 Td
(showing)Tj
-33.3805 -1.2983 Td
(high)Tj
2.0069 0 Td
(specificity)Tj
4.2122 0 Td
(and)Tj
1.7291 0 Td
(sensitivity)Tj
4.2236 0 Td
(for)Tj
1.3833 0 Td
(detecting)Tj
3.8948 0 Td
(and)Tj
1.7291 0 Td
(quantifying)Tj
4.8302 0 Td
(cancer)Tj
2.8403 0 Td
(mutations)Tj
4.286 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
3.5433 0 Td
(Recent)Tj
-34.6788 -1.3039 Td
(French)Tj
3.0387 0 Td
(recommendations)Tj
7.285 0 Td
(,)Tj
0.4422 0 Td
(by)Tj
1.1848 0 Td
(GFCO)Tj
2.8687 0 Td
(based)Tj
2.4774 0 Td
(on)Tj
1.2756 0 Td
(expert)Tj
2.7156 0 Td
(discussion,)Tj
4.5978 0 Td
(proposed)Tj
3.9514 0 Td
(determination)Tj
5.9584 0 Td
(of)Tj
/F13 1 Tf
-35.7956 -1.2983 Td
[()]TJ
/F8 1 Tf
2.5511 0 Td
(mutational)Tj
4.5978 0 Td
(status)Tj
2.5001 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
1.2756 0 Td
(cfDNA)Tj
3.0897 0 Td
(in)Tj
1.0375 0 Td
(second)Tj
3.0104 0 Td
(intention)Tj
3.9288 0 Td
(at)Tj
0.9524 0 Td
(diagnostic,)Tj
4.5411 0 Td
(when)Tj
2.4038 0 Td
(tissue)Tj
2.4604 0 Td
(is)Tj
0.8447 0 Td
(not)Tj
-35.6652 -1.2982 Td
(available,)Tj
3.8891 0 Td
(and)Tj
1.7291 0 Td
(in)Tj
1.0375 0 Td
(first)Tj
1.8084 0 Td
(intention)Tj
3.9232 0 Td
(for)Tj
1.3889 0 Td
(patient)Tj
3.0047 0 Td
(with)Tj
2.0013 0 Td
(progression)Tj
4.9152 0 Td
(under)Tj
2.6192 0 Td
(EGFR-TKIs)Tj
4.9946 0 Td
(therapy)Tj
3.2429 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
-33.3579 -1.3039 Td
(In)Tj
1.1111 0 Td
(the)Tj
1.4684 0 Td
(current)Tj
3.1861 0 Td
(study,)Tj
2.6135 0 Td
(we)Tj
1.3266 0 Td
(assessed)Tj
3.4753 0 Td
(a)Tj
0.6519 0 Td
(newly)Tj
2.5796 0 Td
(developed)Tj
4.2689 0 Td
(digital)Tj
2.7269 0 Td
(PCR)Tj
2.0636 0 Td
(platform,)Tj
3.9288 0 Td
(the)Tj
1.4684 0 Td
(Naica)Tj
2.5171 0 Td
(system)Tj
-34.5824 -1.2983 Td
(for)Tj
1.3832 0 Td
(Crystal)Tj
3.0501 0 Td
(Digital)Tj
2.9367 0 Td
(PCR,)Tj
2.2847 0 Td
(to)Tj
1.0261 0 Td
(detect)Tj
2.6192 0 Td
(and)Tj
1.7291 0 Td
(quantify)Tj
/F13 1 Tf
3.5433 0 Td
[()]TJ
/F8 1 Tf
2.5512 0 Td
(sensitizing)Tj
4.439 0 Td
(and)Tj
1.7291 0 Td
(resistance)Tj
4.1329 0 Td
(mutations)Tj
4.2803 0 Td
(in)Tj
-35.7049 -1.2983 Td
(the)Tj
1.4683 0 Td
(blood)Tj
2.5171 0 Td
(of)Tj
1.0148 0 Td
(advanced)Tj
/F13 1 Tf
3.9912 0 Td
[(\r)14(\r)]TJ
/F8 1 Tf
3.1408 0 Td
(patients.)Tj
3.5943 0 Td
(This)Tj
1.9842 0 Td
(platform)Tj
3.702 0 Td
(generates)Tj
3.9685 0 Td
(2D)Tj
1.4343 0 Td
(arrays)Tj
2.6476 0 Td
(of)Tj
1.0148 0 Td
(monodispersed)Tj
-30.4779 -1.3039 Td
(droplets)Tj
3.4695 0 Td
(in)Tj
1.0375 0 Td
(a)Tj
0.652 0 Td
(microfluidic)Tj
5.159 0 Td
(chip)Tj
1.9559 0 Td
(which)Tj
2.6475 0 Td
(is)Tj
0.8504 0 Td
(subsequently)Tj
5.4028 0 Td
(thermocycled,)Tj
5.896 0 Td
(then)Tj
2.0183 0 Td
(imaged)Tj
3.1578 0 Td
(using)Tj
2.3867 0 Td
(a)Tj
0.652 0 Td
(fluo-)Tj
-35.2854 -1.2982 Td
(rescent)Tj
3.067 0 Td
(microscope.)Tj
5.0683 0 Td
(Taking)Tj
3.0444 0 Td
(advantage)Tj
4.235 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(3)Tj
0.6916 0 Td
(distinct)Tj
3.2145 0 Td
(fluorescence)Tj
5.1873 0 Td
(channels)Tj
3.7304 0 Td
(available,)Tj
3.8948 0 Td
(we)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 461.8204 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(cfDNA)Tj
3.0756 0 Td
(mutations)Tj
4.4858 0 Td
(and)Tj
1.8496 0 Td
(digital)Tj
2.7709 0 Td
(PCR)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01833)Tj
4.089 0 Td
(19)Tj
0 g
2.0906 0 Td
(August)Tj
3.2882 0 Td
(22,)Tj
1.5874 0 Td
(2017)Tj
34.0302 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(10)Tj
/F10 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(and)Tj
1.5874 0 Td
(MD,)Tj
1.7858 0 Td
(and)Tj
1.5874 0 Td
(material)Tj
3.189 0 Td
(support)Tj
3.0969 0 Td
(by)Tj
1.1126 0 Td
(providing)Tj
-12.3591 -1.3748 Td
(consumabl)Tj
4.1031 0 Td
(es)Tj
1.063 0 Td
(\(Sapphire)Tj
3.8197 0 Td
(chips\))Tj
2.5087 0 Td
(and)Tj
1.5874 0 Td
(equipment)Tj
-13.0819 -1.3749 Td
(\(Naica)Tj
2.5724 0 Td
(system\))Tj
3.2244 0 Td
(free)Tj
1.6229 0 Td
(of)Tj
0.9496 0 Td
(charge)Tj
2.7355 0 Td
(to)Tj
0.9496 0 Td
(Gustave-Rous)Tj
5.2654 0 Td
(sy)Tj
-17.3198 -1.3748 Td
(for)Tj
1.2543 0 Td
(this)Tj
1.5661 0 Td
(study.)Tj
2.4875 0 Td
(The)Tj
1.5874 0 Td
(funder)Tj
2.6291 0 Td
(had)Tj
1.5874 0 Td
(no)Tj
1.1623 0 Td
(role)Tj
1.6157 0 Td
(in)Tj
0.8859 0 Td
(study)Tj
-14.7757 -1.3748 Td
(design,)Tj
2.8984 0 Td
(data)Tj
1.7929 0 Td
(collection)Tj
3.7418 0 Td
(and)Tj
1.5874 0 Td
(analysis,)Tj
3.4087 0 Td
(decision)Tj
3.2953 0 Td
(to)Tj
-16.7245 -1.3748 Td
(publish,)Tj
3.1464 0 Td
(or)Tj
0.9993 0 Td
(preparation)Tj
4.4433 0 Td
(of)Tj
0.9496 0 Td
(the)Tj
1.3677 0 Td
(manuscript.)Tj
/F9 1 Tf
-10.9063 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F10 1 Tf
0.4819 0 Td
(Stilla)Tj
1.9985 0 Td
(Technologi)Tj
4.0677 0 Td
(es)Tj
1.063 0 Td
(funded)Tj
-15.3213 -1.3748 Td
(the)Tj
1.3677 0 Td
(travel)Tj
2.2394 0 Td
(grant)Tj
2.1543 0 Td
(for)Tj
1.2544 0 Td
(CJ)Tj
1.1693 0 Td
(to)Tj
0.9496 0 Td
(attend)Tj
2.5157 0 Td
(and)Tj
1.5945 0 Td
(present)Tj
2.9906 0 Td
(at)Tj
0.9 0 Td
(an)Tj
-17.1355 -1.3748 Td
(international)Tj
4.7764 0 Td
(Meeting.)Tj
3.437 0 Td
(This)Tj
1.7788 0 Td
(commercial)Tj
4.5779 0 Td
(affiliation)Tj
-14.5701 -1.3748 Td
(does)Tj
2.0126 0 Td
(not)Tj
1.4173 0 Td
(alter)Tj
1.8213 0 Td
(our)Tj
1.474 0 Td
(adherence)Tj
4.0536 0 Td
(to)Tj
0.9496 0 Td
(PLOS)Tj
2.3315 0 Td
(ONE)Tj
1.8709 0 Td
(policies)Tj
-15.9308 -1.3749 Td
(on)Tj
1.1693 0 Td
(sharing)Tj
2.9834 0 Td
(data)Tj
1.7859 0 Td
(and)Tj
1.5945 0 Td
(material)Tj
ET
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
BT
10.4953 69.591 Td
(s.)Tj
ET
Q
endstream
endobj
55 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 61 0 R/Contents 62 0 R/TrimBox[0 0 612 792]>>
endobj
60 0 obj
<>stream
x|{>;"5nnzoHBG )>VTEQ)bÊ "M}M4{g;;;{sxo?6۽qwniw?o?x}xGO_x+vos=wq]wuO:oLr?ѮZ,y4iҤ_F+/|ĉ]tK^>>`ǎK{]˻_~ː`_rX~[Lgӏ;6}k77~/6}ɗk>nGB[H@.kO/ydԴzӧv[n